The use of fish oil in the community: Results of a population-based study

Catherine L. Hill; Tiffany K. Gill; Sarah Appleton; Leslie Glen Cleland; Anne W. Taylor; Robert John Adams

doi:10.1093/rheumatology/ken498

The use of fish oil in the community: Results of a population-based study

Catherine L. Hill, Tiffany K. Gill, Sarah Appleton, Leslie Glen Cleland, Anne W. Taylor, Robert John Adams

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Abstract

Sir, Fish oil has been demonstrated to have symptomatic benefits [1] and improve disease activity in RA [2]. In addition, fish oil has been shown to have NSAID-sparing effect in patients with RA [3–6]. Recently, the use of fish oil in patients with early RA has been shown to reduce cardiovascular risk factors in these patients already at increased risk of cardiovascular disease [6]. In addition, reduction in NSAID use is likely to reduce cardiovascular and gastrointestinal harm in these patients. A previous study of complementary medicine use in outpatients with OA showed 5% were taking fish oil supplements [7]. Fish oil is widely marketed to the general public for joint and general health benefits. We undertook this population-based study to determine the use of fish oil and its effects in the community.

Original language	English
Pages (from-to)	441-442
Number of pages	2
Journal	Rheumatology
Volume	48
Issue number	4
DOIs	https://doi.org/10.1093/rheumatology/ken498
Publication status	Published - 27 Jan 2009
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/rheumatology/ken498Licence: In Copyright

Cite this

@article{1ff214eed92c4168ad6c0b19d62d17b6,

title = "The use of fish oil in the community: Results of a population-based study",

abstract = "Sir, Fish oil has been demonstrated to have symptomatic benefits [1] and improve disease activity in RA [2]. In addition, fish oil has been shown to have NSAID-sparing effect in patients with RA [3–6]. Recently, the use of fish oil in patients with early RA has been shown to reduce cardiovascular risk factors in these patients already at increased risk of cardiovascular disease [6]. In addition, reduction in NSAID use is likely to reduce cardiovascular and gastrointestinal harm in these patients. A previous study of complementary medicine use in outpatients with OA showed 5% were taking fish oil supplements [7]. Fish oil is widely marketed to the general public for joint and general health benefits. We undertook this population-based study to determine the use of fish oil and its effects in the community.",

author = "Hill, {Catherine L.} and Gill, {Tiffany K.} and Sarah Appleton and Cleland, {Leslie Glen} and Taylor, {Anne W.} and Adams, {Robert John}",

year = "2009",

month = jan,

day = "27",

doi = "10.1093/rheumatology/ken498",

language = "English",

volume = "48",

pages = "441--442",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - The use of fish oil in the community

T2 - Results of a population-based study

AU - Hill, Catherine L.

AU - Gill, Tiffany K.

AU - Appleton, Sarah

AU - Cleland, Leslie Glen

AU - Taylor, Anne W.

AU - Adams, Robert John

PY - 2009/1/27

Y1 - 2009/1/27

N2 - Sir, Fish oil has been demonstrated to have symptomatic benefits [1] and improve disease activity in RA [2]. In addition, fish oil has been shown to have NSAID-sparing effect in patients with RA [3–6]. Recently, the use of fish oil in patients with early RA has been shown to reduce cardiovascular risk factors in these patients already at increased risk of cardiovascular disease [6]. In addition, reduction in NSAID use is likely to reduce cardiovascular and gastrointestinal harm in these patients. A previous study of complementary medicine use in outpatients with OA showed 5% were taking fish oil supplements [7]. Fish oil is widely marketed to the general public for joint and general health benefits. We undertook this population-based study to determine the use of fish oil and its effects in the community.

AB - Sir, Fish oil has been demonstrated to have symptomatic benefits [1] and improve disease activity in RA [2]. In addition, fish oil has been shown to have NSAID-sparing effect in patients with RA [3–6]. Recently, the use of fish oil in patients with early RA has been shown to reduce cardiovascular risk factors in these patients already at increased risk of cardiovascular disease [6]. In addition, reduction in NSAID use is likely to reduce cardiovascular and gastrointestinal harm in these patients. A previous study of complementary medicine use in outpatients with OA showed 5% were taking fish oil supplements [7]. Fish oil is widely marketed to the general public for joint and general health benefits. We undertook this population-based study to determine the use of fish oil and its effects in the community.

U2 - 10.1093/rheumatology/ken498

DO - 10.1093/rheumatology/ken498

M3 - Article

SN - 1462-0324

VL - 48

SP - 441

EP - 442

JO - Rheumatology

JF - Rheumatology

IS - 4

ER -

The use of fish oil in the community: Results of a population-based study

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this